BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 19737784)

  • 1. Regulatory T cells: how do they suppress immune responses?
    Sakaguchi S; Wing K; Onishi Y; Prieto-Martin P; Yamaguchi T
    Int Immunol; 2009 Oct; 21(10):1105-11. PubMed ID: 19737784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of peripheral tolerance and immune regulation mediated by Treg.
    Sakaguchi S; Wing K; Yamaguchi T
    Eur J Immunol; 2009 Sep; 39(9):2331-6. PubMed ID: 19662638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA-4 control over Foxp3+ regulatory T cell function.
    Wing K; Onishi Y; Prieto-Martin P; Yamaguchi T; Miyara M; Fehervari Z; Nomura T; Sakaguchi S
    Science; 2008 Oct; 322(5899):271-5. PubMed ID: 18845758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of foxp3+ T regulatory cell-mediated suppression.
    Shevach EM
    Immunity; 2009 May; 30(5):636-45. PubMed ID: 19464986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
    Oderup C; Cederbom L; Makowska A; Cilio CM; Ivars F
    Immunology; 2006 Jun; 118(2):240-9. PubMed ID: 16771859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding and converting regulatory T cells: a horizon for immunotherapy.
    Khattar M; Chen W; Stepkowski SM
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice.
    Kolar P; Knieke K; Hegel JK; Quandt D; Burmester GR; Hoff H; Brunner-Weinzierl MC
    Arthritis Rheum; 2009 Jan; 60(1):123-32. PubMed ID: 19116935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
    Chen X; Du Y; Huang Z
    Immunol Lett; 2012; 148(1):83-9. PubMed ID: 23000301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?
    Curotto de Lafaille MA; Lafaille JJ
    Immunity; 2009 May; 30(5):626-35. PubMed ID: 19464985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation.
    Wing K; Yamaguchi T; Sakaguchi S
    Trends Immunol; 2011 Sep; 32(9):428-33. PubMed ID: 21723783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
    Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
    Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural regulatory T cells: mechanisms of suppression.
    Miyara M; Sakaguchi S
    Trends Mol Med; 2007 Mar; 13(3):108-16. PubMed ID: 17257897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-restricted CD80/86 deficiency results in peripheral regulatory T-cell reduction but is not associated with lymphocyte hyperactivation.
    Bar-On L; Birnberg T; Kim KW; Jung S
    Eur J Immunol; 2011 Feb; 41(2):291-8. PubMed ID: 21267999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology. Damping by depletion.
    Sakaguchi S; Wing K
    Science; 2011 Apr; 332(6029):542-3. PubMed ID: 21527700
    [No Abstract]   [Full Text] [Related]  

  • 17. How do CD4+CD25+ regulatory T cells control autoimmunity?
    Bluestone JA; Tang Q
    Curr Opin Immunol; 2005 Dec; 17(6):638-42. PubMed ID: 16209918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of antigen-expressing dendritic cells by double negative regulatory T cells.
    Gao JF; McIntyre MS; Juvet SC; Diao J; Li X; Vanama RB; Mak TW; Cattral MS; Zhang L
    Eur J Immunol; 2011 Sep; 41(9):2699-708. PubMed ID: 21660936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD25 shedding by human natural occurring CD4+CD25+ regulatory T cells does not inhibit the action of IL-2.
    Pedersen AE; Lauritsen JP
    Scand J Immunol; 2009 Jul; 70(1):40-3. PubMed ID: 19522766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The shiitake mushroom-derived immuno-stimulant lentinan protects against murine malaria blood-stage infection by evoking adaptive immune-responses.
    Zhou LD; Zhang QH; Zhang Y; Liu J; Cao YM
    Int Immunopharmacol; 2009 Apr; 9(4):455-62. PubMed ID: 19189863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.